PMC:7405836 / 123220-123412 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T200","span":{"begin":35,"end":36},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T201","span":{"begin":78,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0007836"}],"text":"However, with genetic engineering, a 288-330+/+ MERS-CoV genetically modified mouse model was developed and now is in use for the assessment of novel drugs and vaccines against MERS-CoV (220)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T293","span":{"begin":150,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A293","pred":"chebi_id","subj":"T293","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"However, with genetic engineering, a 288-330+/+ MERS-CoV genetically modified mouse model was developed and now is in use for the assessment of novel drugs and vaccines against MERS-CoV (220)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T832","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, with genetic engineering, a 288-330+/+ MERS-CoV genetically modified mouse model was developed and now is in use for the assessment of novel drugs and vaccines against MERS-CoV (220)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3369","span":{"begin":48,"end":56},"obj":"Species"},{"id":"3370","span":{"begin":78,"end":83},"obj":"Species"},{"id":"3371","span":{"begin":177,"end":185},"obj":"Species"}],"attributes":[{"id":"A3369","pred":"tao:has_database_id","subj":"3369","obj":"Tax:1335626"},{"id":"A3370","pred":"tao:has_database_id","subj":"3370","obj":"Tax:10090"},{"id":"A3371","pred":"tao:has_database_id","subj":"3371","obj":"Tax:1335626"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, with genetic engineering, a 288-330+/+ MERS-CoV genetically modified mouse model was developed and now is in use for the assessment of novel drugs and vaccines against MERS-CoV (220)."}